title: In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
abstract: The effect of in vivo administered interferon-alpha (IFN-alpha) on 2-5-oligoadenylate (A) synthetase activity of peripheral blood mononuclear cells (PBMC) was compared in patients with hairy cell leukemia and renal cell cancer. Basic levels of this enzyme varied from donor to donor, but mean levels were not significantly different in patients with renal cell cancer or hairy cell leukemia compared to healthy donors. After a single injection of 3 x 10(6) IU IFN, these basic levels rose 2- to 8-fold within 12-24 h post-injection and reverted to pretreatment levels after 48 h. The extent of this in vivo stimulation by IFN-alpha was similar in patients with hairy cell leukemia and renal cell carcinoma, and was correlated with down-regulation of IFN-alpha receptors. The in vitro effects of IFN-alpha, -beta and -gamma were compared after 18 h treatment with 10, 10(2) and 10(3) IU/ml of each IFN. Unlike IFN-alpha and -beta, IFN-gamma did not induce 2-5 A synthetase activity in either normal PBMC or hairy cells; these results were related to the effects of the three IFN on proliferative response of normal PBMC to phytohemagglutinin. Our data support the idea that 2-5 A synthetase activity is a marker of biological response to interferon treatment in human cancers.
authors: Inserum U. 245, Centre Inserm Saint-Antoine, Paris, France.
authors: D
authors: D
authors: Ferbus
authors: C
authors: C
authors: Billard
authors: F
authors: F
authors: Sigaux
authors: M N
authors: MN
authors: Thang
authors: E
authors: E
authors: Falcoff
mesh_terms: D015088:2',5'-Oligoadenylate Synthetase / Q000096:biosynthesis*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004790:Enzyme Induction; D006801:Humans; D007370:Interferon Type I / Q000378:metabolism; D007372:Interferons / Q000494:pharmacology*; D007680:Kidney Neoplasms / Q000201:enzymology / Q000628:therapy*; D007943:Leukemia, Hairy Cell / Q000201:enzymology / Q000628:therapy*; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000201:enzymology; D011994:Recombinant Proteins
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins; D007372:Interferons; D015088:2',5'-Oligoadenylate Synthetase